Boeing's $4 Billion Deal Boosts Optimism Amid Recovery

Boeing has announced a significant deal that could bode well for investors. The company's latest agreement involves the sale of 787 Dreamliners to an undisclosed customer, with the deal reportedly worth over $4 billion.

This news comes as Boeing continues its recovery from recent challenges, including production delays and COVID-19-related disruptions. Despite these hurdles, the aerospace giant has been working to improve its efficiency and reduce costs, which could help drive future growth.

Meanwhile, another health-focused company, CVS Health, is showing signs of a rebound after a tough year. The pharmacy chain's stock price has risen by about 10% in recent weeks, driven by improving sales trends and cost-cutting efforts.